Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - goserelin, quantity: 10.8 mg - implant - excipient ingredients: polyglactin - prostate cancer: palliative treatment of metastatic or locally advanced prostate cancer , where suitable for hormonal manipulation. adjuvant and neo-adjuvant therapy in combination with radiotherapy for the management of locally advanced prostate cancer in men suitable for hormonal manipulation.

Israel - inglês - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorders . narcolepsy.